Inventor

LEVITZKI ALEX

IL8 patents

⚠️ This page may combine multiple inventors who share the name “LEVITZKI ALEX”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MAX PLANCK GESELLSCHAFT

3 patents

US5851999ADec 22, 1998

FLK-1 is a receptor for vascular endothelial growth factor

MAX PLANCK GESELLSCHAFT160 citations97

US6872699B2Mar 29, 2005

Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein

MAX PLANCK GESELLSCHAFT6 citations72

US7964399B2Jun 21, 2011

Cell line comprising vector encoding truncated FLK-1 receptor

MAX PLANCK GESELLSCHAFT1 citations51

TARGIMMUNE THERAPEUTICS AG

3 patents

US10543232B2Jan 28, 2020

SUGEN INC

1 patent

US5990141ANov 23, 1999

Treatment of platelet derived growth factor related disorders such as cancers

SUGEN INC189 citations96

UNIV CALIFORNIA

1 patent

US6331555B1Dec 18, 2001

Treatment of platelet derived growth factor related disorders such as cancers

UNIV CALIFORNIA152 citations94

LEVITZKI ALEX

MAX PLANCK GESELLSCHAFT

FLK-1 is a receptor for vascular endothelial growth factor

Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein

Cell line comprising vector encoding truncated FLK-1 receptor

TARGIMMUNE THERAPEUTICS AG

Polyplex of double-stranded RNA and polymeric conjugate

Polyethyleneimine polyethyleneglycol vectors

Method of treating cancer

SUGEN INC

Treatment of platelet derived growth factor related disorders such as cancers

UNIV CALIFORNIA

Treatment of platelet derived growth factor related disorders such as cancers